Follow DCH on Twitter! Like DCH on Facebook! Watch DCH Videos on YouTube! Keep up with DCH by visiting our newsroom!

MD Anderson Ranked No. 1 for Cancer Care in National Survey

8/21/2018

The Lewis and Faye Manderson Cancer Center is proud to be one of 18 Certified Members within the MD Anderson Cancer Network™, a program of The University of Texas MD Anderson Cancer Center. We’re especially proud that our colleagues at MD Anderson were again recognized as the No. 1 cancer center in the nation by US News and World Report. 

Here’s the official release from MD Anderson. And watch this video to learn more about how being an MD Anderson Cancer NetworkTM Certified Member benefits our patients.

MD Anderson ranked No. 1 for cancer care in national survey

(MD Anderson News Release August 13, 2018)

The University of Texas MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. Since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals, and it has ranked first 14 times in the last 17 years.

“MD Anderson is proud and grateful to be recognized once again as the leading cancer center in the nation, an honor that reflects our team’s commitment to ending cancer,” said Peter WT Pisters, M.D., president of MD Anderson. “It is a privilege for our 20,000 employees and 1,000 volunteers to serve those counting on us and to work alongside supportive friends, donors, leaders and advocates in the community.”

In addition to MD Anderson’s top ranking for cancer care, the Head and Neck Surgery service was ranked No. 14 in the Ear, Nose and Throat specialty. Orthopedics and Urology also were rated as “High Performing” areas.

For more than 75 years, MD Anderson has been a global leader in the fight to end cancer. Its extraordinary mission calls for bold approaches that allow MD Anderson to continue setting the standard in cancer prevention, education, research and care. Last year alone, more than 137,000 patients sought MD Anderson’s expertise and nearly 11,000 patients enrolled in clinical trials, making it home to the largest cancer clinical trials program in the world. Through industry partnerships and its Therapeutics Discovery division, MD Anderson is working to develop innovative treatment options with the goal of bringing transformational, life-saving medicines to patients quickly, safely and effectively.   

 

 

Back to News Listing